Plaunotol and Geranylgeraniol Induce Caspase-Mediated Apoptosis in Colon Cancer

Journal of Surgical Research

Volumn 153, Issue 2, 2009, Pages 246-253

  Yoshikawa, Naoyuki ^a,b   Yamada, Jun ^a   Tsuno, Nelson H ^a   Okaji, Yurai ^a   Kawai, Kazushige ^a   Tsuchiya, Takeshi ^a   Yoneyama, Satomi ^a   Tanaka, Junichiro ^a   Shuno, Yasutaka ^a   Nishikawa, Takeshi ^a   Nagawa, Hirokazu ^a   Oshima, Noriko ^b   Takahashi, Koki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Chiba University   (Japan)

Author keywords

apoptosis; caspase; colon cancer cell; geranylgeraniol; isoprenoids; plaunotol

Indexed keywords

CASPASE; CASPASE 3; CASPASE 8; CASPASE 9; GERANYLGERANIOL; LIPOCORTIN 5; PLAUNOTOL; PROPIDIUM IODIDE;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STAINING; WESTERN BLOTTING;

ANTI-ULCER AGENTS; APOPTOSIS; CASPASES; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DITERPENES; FATTY ALCOHOLS; HUMANS; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL;

EID: 64849091028     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.04.021     Document Type: Article

References (23)

1. Tanaka M., Obata T., and Sasaki T. Evaluation of antitumour effects of docetaxel (Taxotere) on human gastric cancers in vitro and in vivo. Eur J Cancer 32A (1996) 226
2. Diaz J.F., and Andreu J.M. Assembly of purified GDP-tubulin into microtubules induced by taxol and taxotere: Reversibility, ligand stoichiometry, and competition. Biochemistry 32 (1993) 2747
3. Elson C.E., Peffley D.M., Hentosh P., et al. Isoprenoid-mediated inhibition of mevalonate synthesis: Potential application to cancer. Proc Soc Exp Biol Med 221 (1999) 294
4. Mo H., and Elson C.E. Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. Exp Biol Med (Maywood) 229 (2004) 567
5. Murakami K., Okajima K., Harada N., et al. Plaunotol prevents indomethacin-induced gastric mucosal injury in rats by inhibiting neutrophil activation. Aliment Pharmacol Ther 13 (1999) 521
6. Kawai K., Tsuno N.H., Kitayama J., et al. Anti-angiogenic properties of plaunotol. Anti-Cancer Drugs 16 (2005) 401
7. Yamada J., Kawai K., Tsuno N.H., et al. Plaunotol induces apoptosis of gastric cancer cells. Planta Med 73 (2007) 1068
8. Burke Y.D., Stark M.J., Roach S.L., et al. Inhibition of pancreatic cancer growth by the dietary isoprenoids farnesol and geraniol. Lipids 32 (1997) 151
9. Miquel K., Pradines A., and Favre G. Farnesol and geranylgeraniol induce actin cytoskeleton disorganization and apoptosis in A549 lung adenocarcinoma cells. Biochem Biophys Res Commun 225 (1996) 869
10. Ohizumi H., Masuda Y., Nakajo S., et al. Geranylgeraniol is a potent inducer of apoptosis in tumor cells. J Biochem (Tokyo) 117 (1995) 11
11. Matsumoto Y., Hamashima H., Masuda K., et al. The antibacterial activity of plaunotol against Staphylococcus aureus isolated from the skin of patients with atopic dermatitis. Microbios 96 (1998) 149
12. Takeda Y., Nakao K., Nakata K., et al. Geranylgeraniol, an intermediate product in mevalonate pathway, induces apoptotic cell death in human hepatoma cells: Death receptor-independent activation of caspase-8 with down-regulation of Bcl-xL expression. Jpn J Cancer Res 92 (2001) 918
13. Ohizumi H., Masuda Y., Yoda M., et al. Induction of apoptosis in various tumor cell lines by geranylgeraniol. Anticancer Res 17 (1997) 1051
14. Tomozawa S., Nagawa H., Tsuno N., et al. Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor JTE-522. Br J Cancer 81 (1999) 1274
15. Ushiyama S., Matsuda K., Asai F., et al. Stimulation of prostaglandin production by (2E,6Z,10E)-7-hydroxymethyl-3,11,15-trimethyl-2,6,10,14-++ +hexadecatetrae n-1-ol (plaunotol), a new anti-ulcer drug, in vitro and in vivo. Biochem Pharmacol 36 (1987) 369
16. Kohda I., Nagai H., Iwai M., et al. Effects of 2-(E-2-decenoylamino)ethyl 2-(cyclohexylethyl) sulfide on various ulcer models in rats. Chem Pharm Bull (Tokyo) 39 (1991) 1828
17. Shiratori K., Watanabe S., Takeuchi T., et al. Effect of plaunotol on release of plasma secretin and pancreatic exocrine secretion in humans. Pancreas 4 (1989) 323
18. Miquel K., Pradines A., Terce F., et al. Competitive inhibition of choline phosphotransferase by geranylgeraniol and farnesol inhibits phosphatidylcholine synthesis and induces apoptosis in human lung adenocarcinoma A549 cells. J Biol Chem 273 (1998) 26179
19. Masuda Y., Nakaya M., Nakajo S., et al. Geranylgeraniol potently induces caspase-3-like activity during apoptosis in human leukemia U937 cells. Biochem Biophys Res Commun 234 (1997) 641
20. Nakajo S., Okamoto M., Masuda Y., et al. Geranylgeraniol causes a decrease in levels of calreticulin and tyrosine phosphorylation of a 36-kDa protein prior to the appearance of apoptotic features in HL-60 cells. Biochem Biophys Res Commun 226 (1996) 741
21. Polverino A.J., and Patterson S.D. Selective activation of caspases during apoptotic induction in HL-60 cells. Effects of a tetrapeptide inhibitor. J Biol Chem 272 (1997) 7013
22. Shidoji Y., Nakamura N., Moriwaki H., et al. Rapid loss in the mitochondrial membrane potential during geranylgeranoic acid-induced apoptosis. Biochem Biophys Res Commun 230 (1997) 58
23. Hengartner M.O. The biochemistry of apoptosis. Nature 407 (2000) 770